LET’S TALK ABOUT HIV CARE TOGETHER

LET’S TALK ABOUT HIV
CARE TOGETHER

THE BEST HIV CARE STARTS WITH A CONVERSATION

With more HIV treatment and prevention options available than ever before, now is the time for more open and honest conversations between individuals and their healthcare professionals (HCPs). 

When people feel comfortable asking HCPs questions about options for HIV treatment or prevention, and can talk about more than just their health, it can have a significant impact on treatment satisfaction, adherence and overall health. But 3 in 4 people living with HIV say there’s at least one issue they’re uncomfortable discussing with their HCP, and for some HCPs1, uncovering the experiences of their patients beyond viral load can be difficult.​

Finding the optimal HIV treatment or preventative approach goes beyond viral suppression or efficacy; factors such as tolerability, drug-to-drug interactions, adherence, daily schedules, experiences of stigma, long-term health goals – can all impact a person’s choice in different ways. 

What remains the same is what’s needed to make that choice; a trusted relationship between an individual and their HCP, built on understanding and empathy, with a willingness to tackle the difficult questions together.

Living with HIV has changed. People today can expect more from their HIV medicines. We want people living with HIV or those who could benefit from PrEP to feel comfortable asking for more, raising their concerns or long term health goals and for HCPs to consider more. We want to start the conversations.

Choice is what makes it easier. Knowing that I have options, I have a choice. I can always pick up the phone and say, "This isn't working for me" and my providers will move heaven and earth to make sure that something changes so that it does.

Mercy Shibemba, living with HIV since birth

TALKING ABOUT HIV CARE

A woman born with HIV; two women navigating the world of HIV PrEP; a single father living with HIV; a devoted doctor who has been focused on HIV since the beginning. These are real conversations and real stories that highlight the value of creating strong relationships between healthcare providers and people on an HIV journey.

We partnered with The Skin Deep, an Emmy award winning company that creates content to foster deep conversations to bring together people living with HIV, people with reasons for HIV prevention, and HCPs to explore their relationships, to challenge how they connect when it comes to talking about HIV treatment and prevention, and to tackle the difficult questions together. These conversations are emotional. They can be uncomfortable. Sometimes they’re joyful! But most important, these conversations are real.

Take a peek inside the conversations and explore tools for how to strengthen relationships in HIV care.

START YOUR OWN CONVERSATIONS

There are resources available to facilitate and improve conversations about HIV treatment and prevention. 

Talking to your doctor about your HIV and working together with your healthcare team to understand what's going on within your body may be the best way to get the most from your HIV care.

Once you've settled into your treatment regimen and the virus is undetectable, you’ll likely only need to visit your clinic once or twice a year. Some of these appointments may even be online or over the phone.

At ViiV healthcare, our goal is ambitious, yet clear: we want to end the HIV epidemic. We believe we have the tools to achieve this goal through continuous innovation, talented people and global partnerships that help us reach the communities that are disproportionately impacted by HIV. We must keep investing in the global HIV response.

References:

  1. ViiV Healthcare. Positive Perspectives Study, Wave 2 Results Report. Available at: https://viivhealthcare.com/content/dam/cf-viiv/viivhealthcare/en_GB/files/211203-updated-pp2-report-v9.0.pdf. Last accessed: September 2024.

NP-GBL-HVX-COCO-240046 October 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.